Prognostic Value of Nocturnal Melatonin Levels as a Novel Marker in Patients With ST-Segment Elevation Myocardial Infarction

American Journal of Cardiology

Volumn 97, Issue 8, 2006, Pages 1162-1164

  Dominguez Rodriguez, Alberto ^a   Abreu Gonzalez, Pedro ^b   Garcia Gonzalez, Martín ^a   Reiter, Russel J ^c  

^a HOSPITAL UNIVERSITARIO DE CANARIAS   (Spain)

^b UNIVERSIDAD DE LA LAGUNA   (Spain)

^c Mays Cancer Center at UT Health San Antonio   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; MELATONIN;

ADULT; AGED; ARTICLE; CARDIAC PATIENT; CARDIOVASCULAR EFFECT; CIRCULATION; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; ST SEGMENT ELEVATION;

AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CIRCADIAN RHYTHM; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; LOGISTIC MODELS; MALE; MELATONIN; MIDDLE AGED; MYOCARDIAL INFARCTION; PROGNOSIS; PROSPECTIVE STUDIES;

EID: 33645750415     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2005.11.033     Document Type: Article

References (19)

1. Reiter R.J. Pineal melatonin. Cell biology of its synthesis and of its physiological interactions. Endocr Rev 12 (1991) 151-180
2. Zaidan R., Geoffriau M., and Brun J. Melatonin able to influence its secretion in humans. description of a phase-response curve. Neuroendocrinology 60 (1994) 105-112
3. Sewerynek E. Melatonin and the cardiovascular system. Neuroendocrinol Lett 23 (2002) 79-83
4. Ridker P.M. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 107 (2003) 363-369
5. Berk B.C., Weintraub W.S., and Alexander R.W. Elevation of C-reactive protein in "active" coronary artery disease. Am J Cardiol 65 (1990) 168-172
6. Pang C.S., Xi S.C., and Yau M.Y.C. Melatonin receptors in the chick heart. modulation on isoproterenol stimulated cAMP level. Biol Signals Recept 7 (1998) 268-269
7. Pang C.S., Xi S.C., Brown G.M., Pang S.F., and Shiu S.Y. 2[125I]Iodomelatonin binding and interaction with beta-adrenergic signaling in chick heart/coronary artery physiology. J Pineal Res 32 (2002) 243-252
8. Ekmekcioglu C., Haslmayer P., Philipp C., Mehrabi M.R., Glogar H.D., Grimm M., Leibetseder V.J., Thalhammer T., and Marktl W. Expression of the MT1 melatonin receptor subtype in human coronary arteries. J Recept Signal Transduct Res 21 (2001) 85-91
9. 1, melatonin receptor subtype in coronary arteries derived from patients with coronary heart disease. Chronobiol Int 18 (2001) 973-985
10. 2 is present in the human cardiovascular system. J Pineal Res 35 (2003) 40-44
11. Kelly M.R., and Loo G. Melatonin inhibits oxidative modification of human low-density lipoprotein. J Pineal Res 22 (1997) 203-209
12. Dominguez-Rodriguez A., Abreu-Gonzalez P., Garcia-Gonzalez M., Ferrer-Hita J., Vargas M., and Reiter R.J. Elevated levels of oxidized low-density lipoprotein and impaired nocturnal synthesis of melatonin in patients with myocardial infarction. Atherosclerosis 180 (2005) 101-105
13. Reiter R.J., and Tan D.X. Melatonin. a novel protective agent against oxidative injury of the ischemic/reperfused heart. Cardiovasc Res 58 (2003) 10-19
14. Tan D.X., Manchester L.C., Burkhardt S., Sainz R.M., Mayo J.C., Kohen R., Shohami E., Huo Y.S., Hardeland R., and Reiter R.J. N-acetyl-N-formyl-5-methoxykynuramine, a biogenic amine and melatonin metabolite, functions as a potent antioxidant. FASEB J 15 (2001) 2294-2296
15. Rodriguez C., Mayo J.C., Sainz R.M., Antolin I., Herrera F., Martin V., and Reiter R.J. Regulation of antioxidant enzymes. a significant role for melatonin. J Pineal Res 36 (2004) 1-9
16. Arangino S., Cagnacci A., Angiolucci M., Vacca A.M., Longu G., Volpe A., and Melis G.B. Effects of melatonin on vascular reactivity, catecholamine levels, and blood pressure in healthy men. Am J Cardiol 83 (1999) 1417-1419
17. Cagnacci A., Arangino S., Angiolucci M., Maschio E., and Melis G.B. Influence of melatonin administration on the circulation of women. Am J Physiol 274 suppl (1998) R335-R338
18. Nishiyama K., Yasue H., Moriyama Y., Tsunoda R., Ogawa H., Yoshimura M., and Kugiyama K. Acute effects of melatonin administration on cardiovascular autonomic regulation in healthy men. Am Heart J 141 suppl (2001) E9
19. Dominguez-Rodriguez A., Abreu-Gonzalez P., Garcia-Gonzalez M., Sanchez J., Marrero F., and Armas-Trujillo D. Decreased nocturnal melatonin levels during acute myocardial infarction. J Pineal Res 33 (2002) 248-252